The Stop TB Partnership has made the Infectious Diseases Society of America an organizational member of its TB/HIV working group, a reflection of IDSA’s increasingly visible work on these twin global health threats.
Housed within the World Health Organization, the Stop TB Partnership was formed more than a decade ago as a network of international organizations, donors, governmental and non-governmental groups—all committed to eliminating the deadly scourge of TB. The Partnership has seven working groups to focus energy and attention on specific challenges in fighting TB, including drug-resistant TB, new TB drugs, and DOTS expansion.
IDSA’s membership in the TB/HIV working group will provide a new mechanism to advocate for improvements in policies and programs designed to combat these two epidemics, which have formed a deadly synergy that threatens to unravel gains in treating HIV. Christine Lubinski, IDSA’s vice president for global health, will serve as IDSA’s representative on the TB/HIV working group.
In ratifying a proposal to accept IDSA, the Partnership took note of IDSA’s recent work on co-infection through its Center for Global Health Policy. In particular, the Partnership drew attention to the Global Center’s call for a Presidential Initiative on TB and for a comprehensive strategy to combat HIV/TB co-infection, as detailed in “Deadly Duo: The Synergy Between HIV/AIDS & Tuberculosis.”